Another meta-analysis including 105 publications and 8630 patients analyses the frequency of PI3kCA (13%), PTEN (4%), mTOR (3%) and Akt (2%) mutations in head and neck cancer, although data stratified by anatomical location are not reported [135]. This evidence concerns the gene MTOR and head and neck cancer.